Clenbuterol anticorps (HRP)

N° du produit ABIN1414143

Cet anticorps anti- est un anticorps Lapin Polyclonal détectant dans ELISA. Adapté pour .

Aperçu rapide pour Clenbuterol anticorps (HRP) (ABIN1414143)

Antigène: Clenbuterol

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: HRP

Application: ELISA

Détail du produit

Réactivité croisée (Details): Clenbuterol

Purification: Purified by Protein A.

Immunogène: Clenbuterol conjugated to KLH

Isotype: IgG

Information d'application

Indications d'application: ELISA 1:500-1000

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 μg/μL

Buffer: Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.

Agent conservateur: Gentamicin sulfate

Précaution d'utilisation: This product contains Gentamicin sulfate: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Conseil sur la manipulation: Do NOT add Sodium Azide! Use of Sodium Azide will inhibit enzyme activity of horseradish peroxidase.

Stock: -20 °C

Stockage commentaire: Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.

Date de péremption: 12 months

Détail du antigène

Antigène: Clenbuterol

Classe de substances: Chemical

Sujet:

Synonyms: 1 4 amino 3 5 dichloro phenyl 2 tert butylaminoethanol, Spiropent, Clenbuterol.

Background: Clenbuterol belongs to the group of agonists. In livestock production clenbuterol improves the meat/fat ratio in fattened animals or accelerate the growth. Up to now agonists have not been authorized as adjuvants for fattening. In addition to its lipolytic and anabolic effect, clenbuterol has a relaxing effect on non-striated musculature on which is based its therapeutic use as an antiasthmatic and a tocolytic agent. Clenbuterol is a long acting beta 2 adrenergic agonist. Like other beta 2 agonists, clenbuterol is believed to act by stimulating production of cyclic AMP through the activation of adenyl cyclase. By definition, Beta 2 agonists have more smooth muscle relaxation activity (bronchial, vascular and uterine smooth muscle) versus its cardiac effects (Beta 1).